Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implantable Gestrinone vs Oral Dienogest in Endometriosis
NCT06543550Phase 4Recruiting
- Sponsor
- Bio Meds Pharmaceutica
- Start
- Jul 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Gestrinone in endometriosis, sponsored by Bio Meds Pharmaceutica. Started Jul 2024; status: recruiting.
02
Drugs
Gestrinone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06543550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543550.